• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAUSCH + LOMB BAUSCH + LOMB VIS100 INJECTOR SYSTEM; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAUSCH + LOMB BAUSCH + LOMB VIS100 INJECTOR SYSTEM; FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL) Back to Search Results
Model Number VIS100
Device Problems Break (1069); Use of Device Problem (1670); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Eye Injury (1845); No Known Impact Or Consequence To Patient (2692)
Event Date 04/23/2019
Event Type  Injury  
Manufacturer Narrative
Investigation of this event is in progress.A follow-up report will be submitted upon completion of investigation.
 
Event Description
It was reported that the lens was removed and replaced with different model lens same diopter intraoperatively due to a broken haptic.
 
Manufacturer Narrative
The product was not returned for evaluation; consequently, no product evaluation was performed.Trend analysis, risk analysis and/or directions for use review were considered acceptable, with the product performing within anticipated rates.The device history record (dhr) was reviewed and there were no discrepancies or unusual findings that relate to the reported issue.Based on the current information, the root cause of the event could not be conclusively determined.However, the most probable cause may be related to operational context, wherein if the intraocular lens (iol) is not loaded according to the directions for use (dfu), the iol haptics could be pinched during the closing process of the cartridge wings.As a consequence, the plunger will elongate the optic from the haptic.The increasing of the advancing force will be directed to the junction (haptic to optic) and may tear the haptic off.It is important to manage the haptics during the closing procedure.This can be ensured with a sterile loading forceps by pressing the optic down and align the haptics towards the optic.If additional information becomes available, an additional investigation will be conducted.No corrective action necessary at this time.
 
Event Description
It should be specified that sutures were required in order to complete the reported surgery.Additional information has been requested, but has not been received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAUSCH + LOMB VIS100 INJECTOR SYSTEM
Type of Device
FOLDERS AND INJECTORS, INTRAOCULAR LENS (IOL)
Manufacturer (Section D)
BAUSCH + LOMB
1400 north goodman st
rochester NY 14609
MDR Report Key8664841
MDR Text Key146911133
Report Number0001313525-2019-00092
Device Sequence Number1
Product Code MSS
Combination Product (y/n)Y
PMA/PMN Number
K133146
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup
Report Date 01/01/2005,05/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/03/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/31/2020
Device Model NumberVIS100
Device Lot Number1880B3
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received07/11/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AKREOS ADVANCED OPTICS IOL
Patient Outcome(s) Other;
-
-